BCHE and Alzheimer disease: Increased cholinergic transmission in response to agonists of acetylcholine receptors or cholinesterase inhibitors improves cognitive processes in neuropsychiatric disorders, such as Alzheimer’s disease (AD) and schizophrenia [21]–[24].